These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15337862)

  • 21. Does the Continuous Performance Test Predict ADHD Symptoms Severity and ADHD Presentation in Adults?
    Baggio S; Hasler R; Giacomini V; El-Masri H; Weibel S; Perroud N; Deiber MP
    J Atten Disord; 2020 Apr; 24(6):840-848. PubMed ID: 30654686
    [No Abstract]   [Full Text] [Related]  

  • 22. Adult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic.
    Roy-Byrne P; Scheele L; Brinkley J; Ward N; Wiatrak C; Russo J; Townes B; Varley C
    Compr Psychiatry; 1997; 38(3):133-40. PubMed ID: 9154368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria.
    Takeda T; Tsuji Y; Kurita H
    Res Dev Disabil; 2017 Apr; 63():59-66. PubMed ID: 28260624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erroneous conclusions: The impact of failing to identify invalid symptom presentation when conducting adult attention-deficit/hyperactivity disorder (ADHD) research.
    Hoelzle JB; Ritchie KA; Marshall PS; Vogt EM; Marra DE
    Psychol Assess; 2019 Sep; 31(9):1174-1179. PubMed ID: 31343208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low self-awareness of ADHD in adults using a self-report screening questionnaire.
    Manor I; Vurembrandt N; Rozen S; Gevah D; Weizman A; Zalsman G
    Eur Psychiatry; 2012 Jul; 27(5):314-20. PubMed ID: 22112307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults.
    McCann BS; Roy-Byrne P
    Compr Psychiatry; 2004; 45(3):175-83. PubMed ID: 15124147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported symptoms of attention-deficit/hyperactivity disorder: rate of endorsement and association with neuropsychological performance in an adult psychiatric sample.
    Schneider BC; Thoering T; Cludius B; Moritz S
    Arch Clin Neuropsychol; 2015 May; 30(3):186-91. PubMed ID: 25851625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported childhood attention-deficit/hyperactivity disorder symptoms are not specific to the disorder.
    Suhr J; Zimak E; Buelow M; Fox L
    Compr Psychiatry; 2009; 50(3):269-75. PubMed ID: 19374973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidity in adults with attention-deficit hyperactivity disorder.
    Cumyn L; French L; Hechtman L
    Can J Psychiatry; 2009 Oct; 54(10):673-83. PubMed ID: 19835674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
    Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
    Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Virtual Reality Continuous Performance Test Utilizing Social Cues for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Eom H; Kim KK; Lee S; Hong YJ; Heo J; Kim JJ; Kim E
    Cyberpsychol Behav Soc Netw; 2019 Mar; 22(3):198-204. PubMed ID: 30672714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
    Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.
    Wilens TE; Biederman J; Wozniak J; Gunawardene S; Wong J; Monuteaux M
    Biol Psychiatry; 2003 Jul; 54(1):1-8. PubMed ID: 12842302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.
    Manor I; Newcorn JH; Faraone SV; Adler LA
    Postgrad Med; 2013 Jul; 125(4):181-90. PubMed ID: 23933905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Utility of Conners Continuous Performance Test-3 for Attention Deficit/Hyperactivity Disorder: A Systematic Review.
    Callan PD; Swanberg S; Weber SK; Eidnes K; Pope TM; Shepler D
    J Atten Disord; 2024 Apr; 28(6):992-1007. PubMed ID: 38317541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms.
    Milberger S; Biederman J; Faraone SV; Murphy J; Tsuang MT
    Am J Psychiatry; 1995 Dec; 152(12):1793-9. PubMed ID: 8526248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of neurocognitive tests in the assessment of adult attention-deficit/hyperactivity disorder.
    Nikolas MA; Marshall P; Hoelzle JB
    Psychol Assess; 2019 May; 31(5):685-698. PubMed ID: 30730189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emotional dysregulation is a primary symptom in adult Attention-Deficit/Hyperactivity Disorder (ADHD).
    Hirsch O; Chavanon M; Riechmann E; Christiansen H
    J Affect Disord; 2018 May; 232():41-47. PubMed ID: 29477097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.